Iqstel Financials
This page shows Iqstel (IQST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Iqstel has an operating margin of -1.3%, meaning the company retains $-1 of operating profit per $100 of revenue. This below-average margin results in a low score of 19/100, suggesting thin profitability after operating expenses. This is down from -0.3% the prior year.
Iqstel's revenue grew 11.9% year-over-year to $316.9M, a solid pace of expansion. This earns a growth score of 53/100.
Iqstel carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Iqstel's current ratio of 1.04 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 16/100, which could limit financial flexibility.
While Iqstel generated -$3.8M in operating cash flow, capex of $113K consumed most of it, leaving -$4.0M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.
Iqstel generates a -52.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -50.3% the prior year.
Iqstel passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Iqstel generates $0.45 in operating cash flow (-$3.8M OCF vs -$8.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Iqstel earns $-7.6 in operating income for every $1 of interest expense (-$4.3M vs $556K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Iqstel generated $316.9M in revenue in fiscal year 2025. This represents an increase of 11.9% from the prior year.
Iqstel's EBITDA was -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 983.4% from the prior year.
Iqstel reported -$8.5M in net income in fiscal year 2025. This represents a decrease of 42.0% from the prior year.
Iqstel earned $-2.86 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 7050.0% from the prior year.
Cash & Balance Sheet
Iqstel generated -$4.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 28.4% from the prior year.
Iqstel held $2.2M in cash against $31K in long-term debt as of fiscal year 2025.
Iqstel had 5M shares outstanding in fiscal year 2025. This represents an increase of 99.9% from the prior year.
Margins & Returns
Iqstel's gross margin was 3.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the prior year.
Iqstel's operating margin was -1.3% in fiscal year 2025, reflecting core business profitability. This is down 1.1 percentage points from the prior year.
Iqstel's net profit margin was -2.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.
Iqstel's ROE was -52.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.9 percentage points from the prior year.
Capital Allocation
Iqstel invested $113K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 25.5% from the prior year.
IQST Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $102.9M+42.5% | $72.2M+25.2% | $57.6M-41.7% | $98.9M+82.3% | $54.2M-31.0% | $78.6M+52.9% | $51.4M+8.8% | $47.3M |
| Cost of Revenue | $100.1M+42.4% | $70.3M+26.2% | $55.7M-42.1% | $96.2M+84.2% | $52.2M-31.7% | $76.5M+52.8% | $50.0M+9.7% | $45.6M |
| Gross Profit | $2.7M+46.4% | $1.9M-3.3% | $1.9M-28.6% | $2.7M+34.1% | $2.0M-6.6% | $2.2M+56.9% | $1.4M-16.0% | $1.6M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $3.3M+30.5% | $2.5M-0.5% | $2.5M-14.2% | $3.0M+42.6% | $2.1M-17.1% | $2.5M+60.4% | $1.6M+7.1% | $1.5M |
| Operating Income | -$559K+14.8% | -$656K-8.6% | -$604K-139.8% | -$252K-345.5% | -$57K+83.5% | -$342K-86.5% | -$183K-199.7% | $184K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $72K-21.6% | $92K+345.7% | $21K | N/A | $70K+6.6% | $65K | N/A | N/A |
| Net Income | -$2.3M+1.0% | -$2.3M-105.2% | -$1.1M+57.2% | -$2.7M-246.0% | -$773K+60.6% | -$2.0M-238.5% | -$580K-18.7% | -$489K |
| EPS (Diluted) | $-0.68+17.1% | $-0.82 | $-0.44 | N/A | $-0.40+55.6% | $-0.90-143.2% | $-0.37 | N/A |
IQST Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $46.9M-8.8% | $51.4M+22.3% | $42.0M-46.8% | $79.0M+143.6% | $32.4M+8.2% | $30.0M+35.6% | $22.1M-0.2% | $22.2M |
| Current Assets | $29.8M-16.1% | $35.6M+36.5% | $26.0M-58.7% | $63.0M+220.4% | $19.7M+14.2% | $17.2M+10.2% | $15.6M-0.6% | $15.7M |
| Cash & Equivalents | $2.3M+10.8% | $2.0M+87.9% | $1.1M-56.8% | $2.5M+18.1% | $2.1M+166.6% | $797K-70.8% | $2.7M+100.0% | $1.4M |
| Inventory | $31K0.0% | $31K0.0% | $31K0.0% | $31K0.0% | $31K+13.8% | $27K0.0% | $27K-0.7% | $27K |
| Accounts Receivable | $24.0M-21.7% | $30.6M+39.4% | $22.0M-61.6% | $57.2M+281.5% | $15.0M+8.8% | $13.8M+52.9% | $9.0M-28.2% | $12.5M |
| Goodwill | $8.0M+17.9% | $6.8M0.0% | $6.8M0.0% | $6.8M-36.8% | $10.7M0.0% | $10.7M+106.4% | $5.2M0.0% | $5.2M |
| Total Liabilities | $29.0M-21.8% | $37.1M+21.8% | $30.5M-54.6% | $67.1M+175.6% | $24.3M+8.6% | $22.4M+63.1% | $13.7M-2.6% | $14.1M |
| Current Liabilities | $28.7M-22.0% | $36.8M+21.7% | $30.3M-52.6% | $63.8M+165.2% | $24.1M+8.4% | $22.2M+64.6% | $13.5M-2.6% | $13.8M |
| Long-Term Debt | $34K-99.2% | $4.5M+26.0% | $3.5M+44.0% | $2.5M-24.0% | $3.2M+27.0% | $2.5M+2720.9% | $90K-9.0% | $99K |
| Total Equity | $17.9M+25.0% | $14.3M+23.6% | $11.6M-2.9% | $11.9M+47.1% | $8.1M+6.8% | $7.6M-9.6% | $8.4M+4.1% | $8.0M |
| Retained Earnings | -$38.9M-7.0% | -$36.4M-7.3% | -$33.9M-3.8% | -$32.7M-9.6% | -$29.8M-3.2% | -$28.9M-7.5% | -$26.9M-3.1% | -$26.1M |
IQST Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$953K-469.8% | $258K+113.5% | -$1.9M-372.4% | -$404K-164.6% | $625K+123.9% | -$2.6M-387.0% | -$537K+48.8% | -$1.0M |
| Capital Expenditures | $16K-64.8% | $46K-6.5% | $49K+179.4% | $18K-42.4% | $31K-4.0% | $32K-55.6% | $72K+29.5% | $55K |
| Free Cash Flow | -$969K-557.9% | $212K+110.8% | -$2.0M-364.4% | -$421K-170.9% | $594K+122.5% | -$2.6M-334.9% | -$609K+44.9% | -$1.1M |
| Investing Cash Flow | -$46K+60.5% | -$115K-96.4% | -$59K+72.4% | -$213K+7.6% | -$230K+79.0% | -$1.1M+32.4% | -$1.6M-20302.8% | $8K |
| Financing Cash Flow | $1.2M+50.4% | $811K+50.0% | $540K-46.0% | $1.0M+7.3% | $933K-47.7% | $1.8M-49.4% | $3.5M+829.0% | $379K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IQST Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 2.7%+0.1pp | 2.6%-0.8pp | 3.4%+0.6pp | 2.7%-1.0pp | 3.7%+1.0pp | 2.8%+0.1pp | 2.7%-0.8pp | 3.5% |
| Operating Margin | -0.5%+0.4pp | -0.9%+0.1pp | -1.1%-0.8pp | -0.3%-0.1pp | -0.1%+0.3pp | -0.4%-0.1pp | -0.4%-0.8pp | 0.4% |
| Net Margin | -2.3%+1.0pp | -3.3%-1.3pp | -2.0%+0.7pp | -2.7%-1.3pp | -1.4%+1.1pp | -2.5%-1.4pp | -1.1%-0.1pp | -1.0% |
| Return on Equity | -13.0%+3.4pp | -16.4%-6.5pp | -9.9%+12.6pp | -22.5%-12.9pp | -9.6%+16.4pp | -25.9%-19.0pp | -6.9%-0.9pp | -6.1% |
| Return on Assets | -5.0%-0.4pp | -4.6%-1.8pp | -2.7%+0.7pp | -3.4%-1.0pp | -2.4%+4.2pp | -6.6%-3.9pp | -2.6%-0.4pp | -2.2% |
| Current Ratio | 1.04+0.1 | 0.96+0.1 | 0.86-0.1 | 0.99+0.2 | 0.82+0.0 | 0.78-0.4 | 1.16+0.0 | 1.14 |
| Debt-to-Equity | 0.00-0.3 | 0.310.0 | 0.31+0.1 | 0.21-0.2 | 0.40+0.1 | 0.34+0.3 | 0.010.0 | 0.01 |
| FCF Margin | -0.9%-1.2pp | 0.3%+3.7pp | -3.4%-3.0pp | -0.4%-1.5pp | 1.1%+4.5pp | -3.4%-2.2pp | -1.2%+1.2pp | -2.3% |
Similar Companies
Frequently Asked Questions
What is Iqstel's annual revenue?
Iqstel (IQST) reported $316.9M in total revenue for fiscal year 2025. This represents a 11.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Iqstel's revenue growing?
Iqstel (IQST) revenue grew by 11.9% year-over-year, from $283.2M to $316.9M in fiscal year 2025.
Is Iqstel profitable?
No, Iqstel (IQST) reported a net income of -$8.5M in fiscal year 2025, with a net profit margin of -2.7%.
What is Iqstel's EBITDA?
Iqstel (IQST) had EBITDA of -$3.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Iqstel have?
As of fiscal year 2025, Iqstel (IQST) had $2.2M in cash and equivalents against $31K in long-term debt.
What is Iqstel's gross margin?
Iqstel (IQST) had a gross margin of 3.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Iqstel's operating margin?
Iqstel (IQST) had an operating margin of -1.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Iqstel's net profit margin?
Iqstel (IQST) had a net profit margin of -2.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Iqstel's return on equity (ROE)?
Iqstel (IQST) has a return on equity of -52.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Iqstel's free cash flow?
Iqstel (IQST) generated -$4.0M in free cash flow during fiscal year 2025. This represents a -28.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Iqstel's operating cash flow?
Iqstel (IQST) generated -$3.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Iqstel's total assets?
Iqstel (IQST) had $51.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Iqstel's capital expenditures?
Iqstel (IQST) invested $113K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Iqstel's current ratio?
Iqstel (IQST) had a current ratio of 1.04 as of fiscal year 2025, which is considered adequate.
What is Iqstel's debt-to-equity ratio?
Iqstel (IQST) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Iqstel's return on assets (ROA)?
Iqstel (IQST) had a return on assets of -16.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Iqstel's cash runway?
Based on fiscal year 2025 data, Iqstel (IQST) had $2.2M in cash against an annual operating cash burn of $3.8M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Iqstel's Piotroski F-Score?
Iqstel (IQST) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Iqstel's earnings high quality?
Iqstel (IQST) has an earnings quality ratio of 0.45x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Iqstel cover its interest payments?
Iqstel (IQST) has an interest coverage ratio of -7.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Iqstel?
Iqstel (IQST) scores 35 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.